At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
Bupivacaine 0.25% +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dose Response Study of Dexamethasone in Combination With Bupivacaine 0.25% in Ultrasound Guided Supraclavicular Brachial Plexus Nerve Block, a Randomized, Placebo Controlled Prospective Clinical Trial
In Brief
A clinical study evaluating Bupivacaine 0.25%, Dexamethasone, and 1 other intervention for Post Surgical Pain. Completed, enrolled 89 participants across 1 site.
Detailed Summary
When used in conjunction with a local anesthetic, dexamethasone may prolong both the sensory and motor effects of high supraclavicular brachial plexus nerve block (SBP) in arthroscopic shoulder surgery. This study seeks to determine if there is a relationship between the duration of sensory and motor blockade in supraclavicular brachial plexus nerve blocks (SBP) when combined with increasing doses of dexamethasone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Surgical Pain
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2012
First PostedSep 2012
Primary CompletionFeb 2015
TodayJul 2026
First PostedSep 24, 2012
Enrollment StartSep 1, 2012
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 13.8 years ago
Interventions
Bupivacaine 0.25%drug
Dexamethasonedrug
normal salinedrug
placebo